From: Gene expression profiles in canine mammary carcinomas of various grades of malignancy
Cellular pathways | 1vs 2 | 1vs 3 | 2vs 3 |
---|---|---|---|
5HT1 type receptor mediated signaling pathway | X | X | |
Alzheimer disease-amyloid secretase pathway | X | X | |
Alzheimer disease-presenilin pathway | X | X | |
Angiogenesis | X | X | |
Apoptosis signaling pathway | X | X | |
B cell activation | X | X | |
Beta1 adrenergic receptor signaling pathway | X | X | |
Beta2 adrenergic receptor signaling pathway | X | X | |
Cadherin signaling pathway | X | X | |
EGF receptor signaling pathway | X | X | |
Endothelin signaling pathway | X | X | X |
GABA-B_receptor_II_signaling | X | X | |
Glycolysis | X | X | |
Hedgehog signaling pathway | X | X | |
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | X | X | |
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | X | X | |
Histamine H2 receptor mediated signaling pathway | X | X | |
Huntington disease | X | X | |
Hypoxia response via HIF activation | X | X | |
Inflammation mediated by chemokine and cytokine signaling pathway | X | X | |
Metabotropic glutamate receptor group II pathway | X | X | |
Metabotropic glutamate receptor group III pathway | X | X | |
Muscarinic acetylcholine receptor 2 and 4 signaling pathway | X | X | |
Oxidative stress response | X | X | X |
PDGF signaling pathway | X | X | |
Parkinson disease | X | X | |
T cell activation | X | X | |
Thyrotropin-releasing hormone receptor signaling pathway | X | ||
Transcription regulation by bZIP transcription factor | X | X | |
Wnt signaling pathway | X | X | |
p53 pathway by glucose deprivation | X | X |